Plus   Neg

Sanofi Agrees To Pay $315 Mln To Settle Contingent Value Rights Litigation

Sanofi (SNYNF,SNY) announced Thursday that it has entered into a settlement agreement related to Contingent Value Rights or CVRs litigation. Sanofi agreed to pay a total of $315 million as part of the agreement.

The agreement is related to the previously disclosed action UMB Bank, N.A., as Trustee v. Sanofi, currently pending in the United States District Court for the Southern District of New York.

The Action involves claims against Sanofi for breach of the Contingent Value Rights Agreement, dated as of March 31, 2011, relating to Sanofi's publicly-traded CVRs issued in connection with the acquisition of Genzyme Corp.

Under the settlement agreement, Sanofi and Plaintiff UMB Bank have agreed to fully and completely resolve the Action, without any admission of liability or wrongdoing.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT